{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:15:58Z","timestamp":1792451758354,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,3]],"date-time":"2027-03-03T00:00:00Z","timestamp":1804032000000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIH NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clim.2026.110687","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:59:26Z","timestamp":1772207966000},"page":"110687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["ADAM9 supports regulatory T cell stability through TGF-\u03b2\u2013SMAD signaling and is reduced in systemic lupus erythematosus"],"prefix":"10.1016","volume":"285","author":[{"given":"Theodoros","family":"Vichos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Karino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limor","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George C.","family":"Tsokos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2026.110687_bb0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","article-title":"Regulatory T cells and human disease","volume":"38","author":"Sakaguchi","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory T cells and Foxp3","volume":"241","author":"Rudensky","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2026.110687_bb0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi4613","article-title":"Transforming growth factor-beta1 in regulatory T cell biology","volume":"7","author":"Moreau","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-beta signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.clim.2026.110687_bb0040","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","article-title":"The immunology of systemic lupus erythematosus","volume":"25","author":"Tsokos","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207790","article-title":"An overview of ADAM9: structure, activation, and regulation in human diseases","volume":"21","author":"Chou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2026.110687_bb0050","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023230118","article-title":"ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-beta1","volume":"118","author":"Umeda","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2026.110687_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/art.42987","article-title":"Hypoxia promotes the expression of ADAM9 by tubular epithelial cells, which enhances transforming growth factor beta1 activation and promotes tissue fibrosis in patients with lupus nephritis","volume":"77","author":"Umeda","year":"2025","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.clim.2026.110687_bb0060","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/art.43313","article-title":"ADAM9 promotes glycolysis in Th17 cells and autoimmunity through activation of IGF-1 signaling","volume":"77","author":"Karino","year":"2025","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.clim.2026.110687_bb0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0070","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.immuni.2017.03.015","article-title":"Transforming growth factor-beta signaling in regulatory T cells controls T Helper-17 cells and tissue-specific immune responses","volume":"46","author":"Konkel","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2026.110687_bb0075","doi-asserted-by":"crossref","first-page":"G135","DOI":"10.1152\/ajpgi.90462.2008","article-title":"T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade","volume":"296","author":"Ostanin","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.clim.2026.110687_bb0080","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/mi.2010.7","article-title":"Molecular mechanisms regulating TGF-beta-induced Foxp3 expression","volume":"3","author":"Xu","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0085","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.20042276","article-title":"TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells","volume":"201","author":"Marie","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110687_bb0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/intimm\/dxp095","article-title":"Regulatory T cells: how do they suppress immune responses?","volume":"21","author":"Sakaguchi","year":"2009","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a021907","article-title":"Regulation of the bioavailability of TGF-beta and TGF-beta-related proteins","volume":"8","author":"Robertson","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.clim.2026.110687_bb0100","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2026.110687_bb0105","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110687_bb0110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/immunohorizons.2200072","article-title":"Anti-GARP antibodies inhibit release of TGF-beta by regulatory T cells via different modes of action, but do not influence their function in vitro","volume":"7","author":"Igney","year":"2023","journal-title":"Immunohorizons"},{"key":"10.1016\/j.clim.2026.110687_bb0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.20020590","article-title":"CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness","volume":"196","author":"Piccirillo","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2026.110687_bb0120","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","article-title":"Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state","volume":"10","author":"Takahashi","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2026.110687_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-61737-979-6_2","article-title":"In vitro Treg suppression assays","volume":"707","author":"Collison","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.clim.2026.110687_bb0130","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/ecco-jcc\/jjy035","article-title":"Development of reliable, valid and responsive scoring systems for endoscopy and histology in animal models for inflammatory bowel disease","volume":"12","author":"Koelink","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.clim.2026.110687_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ibd\/izx014","article-title":"Differential susceptibility to T cell-induced colitis in mice: role of the intestinal microbiota","volume":"24","author":"Reinoso Webb","year":"2018","journal-title":"Inflamm. Bowel Dis."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661626000252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:38:29Z","timestamp":1779190709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661626000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"alternative-id":["S1521661626000252"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2026.110687","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADAM9 supports regulatory T cell stability through TGF-\u03b2\u2013SMAD signaling and is reduced in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2026.110687","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110687"}}